Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spok HoldingsSPOK +1.95%58 3-Year EBITDA Growth Rate is 26.30% as of Jun. 2026. GuruFocus rates SPOK with a GF Score™ of 58/100 and a GF Value™ of $14.47 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Spok Holdings ranks better than 74.14% on this metric.
During the past 12 months, Spok Holdings's average EBITDA Per Share Growth Rate was -15.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 26.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Spok Holdings was 119.20% per year. The lowest was -55.20% per year. And the median was -10.00% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Spok Holdings 3-Year EBITDA Growth Rate Related Terms
SPOK vs SY, AMWL, LFMD: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Spok Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spok Holdings 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spok Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Spok Holdings's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 26.30% mean?
Spok Holdings (SPOK) has a 3-Year EBITDA Growth Rate of 26.30% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Spok Holdings and its competitors. According to the industry distribution chart, Spok Holdings ranks #136 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 25.9%.
Is Spok Holdings' 3-Year EBITDA Growth Rate too high?
Spok Holdings' current 3-Year EBITDA Growth Rate is 26.30%. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.20. Spok Holdings' value of 26.30% is 157.8% above this industry median. Based on the distribution chart, Spok Holdings ranks #136 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Spok Holdings has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spok Holdings' 3-Year EBITDA Growth Rate compare to SY and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Spok Holdings ranks #136 out of 526 companies for 3-Year EBITDA Growth Rate. This puts Spok Holdings in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. Spok Holdings' value of 26.30% is 157.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spok Holdings's current 3-Year EBITDA Growth Rate of 26.30% is 157.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Spok Holdings and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spok Holdings's current 3-Year EBITDA Growth Rate is 26.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spok Holdings stock overvalued right now?
Based on GuruFocus' analysis, Spok Holdings (SPOK) is currently considered Modestly Undervalued. The stock's GF Value™ is $14.47, compared to a current price of $11.51 — trading 20.5% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 26.30% and 157.8% above the Healthcare Providers & Services industry median of 10.20. Spok Holdings' overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Spok Holdings (SPOK), the current 3-Year EBITDA Growth Rate is 26.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spok Holdings (SPOK) Overvalued in 2026?
Based on GuruFocus' analysis, Spok Holdings stock appears to be undervalued.
The current stock price of $11.51 is trading 20.5% below its estimated GF Value™ of $14.47.
GuruFocus considers Spok Holdings to be Modestly Undervalued.
Key valuation signals for SPOK:
3-Year EBITDA Growth Rate: 26.30%
GF Value™: $14.47 vs. price of $11.51 (20.5% below fair value)
Industry Position: 157.8% above the Healthcare Providers & Services median (#136 of 526)
No single metric tells the full story. See the SPOK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
58GF Score
Get the complete analysis for SPOK
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SPOK has been successfully added to your 
